A Missouri appeals court has reversed a $110 million talcum powder verdict against Johnson & Johnson.

Tuesday’s ruling by the Missouri Court of Appeals found that the Virginia plaintiff, Lois Slemp, who alleged she got ovarian cancer in 2012 from using Johnson & Johnson’s baby powder, had no jurisdiction to bring her case in Missouri under the U.S. Supreme Court’s 2017 decision in Bristol-Myers Squibb v. Superior Court of California. The ruling wipes out the fourth verdict in a St. Louis courtroom that helped launch much of the ovarian cancer litigation against Johnson & Johnson.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]